Key Advantages of MicroPlant
- The MicroPlant enables very fast product development using only mg quantities of expensive drug API
- Q-Sphera microsphere manufacture limits the degradation of the protein or peptide drug. The process is very benign and does not involve the use of heat or harsh solvents so no shear stress is applied to fragile biogeneric molecules
- The MicroPlant has very fine control of the size of microspheres produced resulting in identical microspheres with a very narrow particle size distribution
- Uniquely the process leaves minimal residual organic solvents in each microsphere (<10ppb)
- The MicroPlant is a very low dead volume device that results in less wasteage of expensive drug API during the manufacturing process
- The post processing of microspheres produced using the MicroPlant is minimal with no sieving necessary
- High encapsulation efficiency (>85% ) of drug into each microsphere is achieved
